To this end, we injected 50,000 cells from each of control, scramble and TCF12 KO GL261 cells into immunocompetent B6 mice (four mice in each group) and monitored tumor initiation and progression by serial MRIs. The gene discussed is TCF12; the disease is neoplasm.